Non-Invasive Markers for the Detection of Gastric Precancerous Conditions

M Romańczyk, M Osmola, A Link, A Druet, C Hémont… - Cancers, 2024 - mdpi.com
Simple Summary Individuals with atrophic gastritis and gastric intestinal metaplasia,
considered gastric precancerous conditions (GPC), are at increased risk of developing …

Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers

F Mascaretti, S Haider, C Amoroso, F Caprioli… - Journal of …, 2024 - Springer
Purpose Stomach and esophageal cancers are among the highest mortality from cancers
worldwide. Microbiota has an interplaying role within the human gastrointestinal (GI) tract …

Comparison between the GastroPanel test and the serum pepsinogen assay interpreted with the ABC method—A prospective study

SY Lee, YS Ahn, HW Moon - Helicobacter, 2024 - Wiley Online Library
Abstract Background and Aims This study aimed to validate Helicobacter pylori serological
and pepsinogen (PG) assays for detecting infection and gastric neoplasm. Methods …

Effectiveness of serological markers of gastric mucosal atrophy in the gastric precancer screening and in cancer prevention

SM Kotelevets, SA Chekh… - World Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
BACKGROUND New markers are needed to improve the effectiveness of serological
screening for atrophic gastritis. AIM To develop a cost-effective method for serological …

[PDF][PDF] Gastritis by Serological Biomarker Test (GastroPanel® Quick Test) in Gastroscopy Referral Patients in India

M Chhabra, A Kolatkar, S Chawla, A Joshi… - 2025 - preprints.org
Background: Increased demand of the serological biomarker test (GastroPanel®) in
noninvasive diagnosis of gastric cancer (GC) risk conditions, ie, atrophic gastritis (AG) and …